Stocks Health care XTNT
NYSE · Health careXtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. brought in $109.5M of revenue over the twelve months to June 30, 2026, down 14.3% from a year earlier. It posted a net loss of $11.1M. Operating cash flow minus capital spending left $10.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $9.9M in cash against $7.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about Xtant Medical Holdings, Inc.
- Net worth
- Xtant Medical Holdings, Inc. has a market value (market cap) of $38.6M at the latest share price, and shareholders' equity of $40M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $133.9M (+14.2% year on year), with net income of $5M. Over the 12 months to June 30, 2026: revenue $109.5M, net loss $11.1M.
- Cash flow
- In fiscal 2025 operations brought in $12.5M of cash; after $2.4M of capital spending, free cash flow was $10.2M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Xtant Medical Holdings, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What Xtant Medical Holdings, Inc. does
Xtant Medical Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker XTNT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $133.9M | $5M | $0.03 | $10.2M |
| 2024 | $117.3M | -$16.4M | -$0.12 | -$16M |
| 2023 | $91.3M | $660K | $0.01 | -$11M |
| 2022 | $58M | -$8.5M | -$0.09 | -$7.1M |
| 2021 | $55.3M | -$4.8M | -$0.06 | -$1.7M |
| 2020 | $53.3M | -$7M | -$0.25 | -$2.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where XTNT ranks in Health care
Latest SEC filings
What Xtant Medical Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 35% to $23M versus the same quarter last year; diluted EPS -$0.07 versus $0.02.
- August 11, 2026
- August 7, 2026
- June 23, 2026
- June 23, 2026Additional proxy material DEFA14A
- June 23, 2026Proxy statement DEF 14A
- May 29, 2026
- May 13, 2026Form S-8 POS filing S-8 POS
- May 13, 2026Form S-8 POS filing S-8 POS
- May 13, 2026Form S-8 POS filing S-8 POS
What is XTNT worth? A DCF from its reported cash flow
Insider trades
What the people running Xtant Medical Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 11 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 15, 2026 | Bakewell John KDirector | Received as pay | 215,517 | - |
| August 15, 2026 | Lipschultz TylerDirector | Received as pay | 215,517 | - |
| August 15, 2026 | Vizirgianakis Stavros G.Director | Received as pay | 323,275 | - |
| August 15, 2026 | Browne Sean EPresident and CEO, Director | Received as pay | 550,000 | - |
| August 15, 2026 | Browne Sean EPresident and CEO, Director | Shares withheld for tax | 10,605 | $3.3K |
| August 15, 2026 | Neils Scott CCFO and Assistant Secretary | Received as pay | 400,000 | - |
| August 15, 2026 | Neils Scott CCFO and Assistant Secretary | Shares withheld for tax | 28,155 | $8.7K |
| August 15, 2026 | Schallenberger Mark A.Chief Operating Officer | Received as pay | 450,000 | - |
Who owns XTNT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Nantahala Capital Management, LLC13D, may seek influence with 3 related filers | 49.1% | August 5, 2025 |
| Lytton Laurence W13G, passive with 1 related filers | 5.5% | February 17, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 32 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Nantahala Capital Management, LLC | 136,788,000 | +68,394,000 |
| AWM Investment Company, Inc. | 5,976,910 | 0 |
| Vanguard Capital Management LLC | 2,014,603 | 0 |
| Renaissance Technologies LLC | 935,119 | -52,291 |
| Geode Capital Management, LLC | 517,133 | -12,081 |
| Crescent Grove Advisors, LLC | 412,024 | 0 |
| Nano Cap New Millennium Growth Fund L P | 400,000 | +50,000 |
| Vanguard Fiduciary Trust Co | 257,988 | 0 |
| Citadel Advisors LLC | 191,369 | +30,358 |
| Bridgeway Capital Management, LLC | 164,100 | 0 |
| Wiregrass Investment Management LLC | 150,000 | +47,000 |
| BlackRock, Inc. | 115,782 | 0 |
| Mink Brook Asset Management LLC | 109,466 | 0 |
| Northern Trust Corp | 101,127 | +1,529 |
| Millennium Management LLC | 84,490 | -47,864 |
| XTX Topco Ltd | 68,531 | +30,598 |
| UBS Group AG | 31,920 | new |
| State Street Corp | 31,266 | 0 |
| Sei Investments Co | 24,760 | 0 |
| Kestra Advisory Services, LLC | 20,000 | 0 |
Insiders
8 insiders reported holding 15,885,086 shares in total, about $4.4M at the last price.
| Holder | Shares |
|---|---|
| Vizirgianakis Stavros G.Director | 7,838,845 |
| Browne Sean EPresident and CEO, Director | 3,114,669 |
| Neils Scott CCFO and Assistant Secretary | 1,215,226 |
| Bakewell John KDirector | 1,129,633 |
| Schallenberger Mark A.Chief Operating Officer | 1,106,087 |
| Beeson Jonn R.Director | 733,136 |
| Lipschultz TylerDirector | 373,745 |
| Jain AbhinavDirector | 373,745 |
Questions about XTNT
What does Xtant Medical Holdings, Inc. do?
Xtant Medical Holdings, Inc. is a company in the Health care sector, listed on NYSE as XTNT. Its shares trade on NYSE under the ticker XTNT.
What is Xtant Medical Holdings, Inc.'s net worth?
Xtant Medical Holdings, Inc. has a market value (market cap) of $38.6M at the latest share price, and shareholders' equity of $40M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Xtant Medical Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $11.1M on revenue of $109.5M.
How much revenue does Xtant Medical Holdings, Inc. make?
Over the twelve months to June 30, 2026 Xtant Medical Holdings, Inc. reported revenue of $109.5M. That is 14.3% less than a year earlier.
When did Xtant Medical Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 18, 2026.
When is Xtant Medical Holdings, Inc.'s next earnings report?
Xtant Medical Holdings, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare XTNT with
Follow XTNT
Get an email when Xtant Medical Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Xtant Medical Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.